| Q113209188 | A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain |
| Q73208799 | Acquired C1 esterase inhibitor deficiency |
| Q28324688 | Acute renal insufficiency with IgE specific RAST induced by amoxicillin in a 9-month-old infant |
| Q45047929 | Algorithm for diagnosis and treatment of hereditary angioedema as a tool for management |
| Q73716469 | Allergic reactions to anisakis simplex parasitizing seafood |
| Q38405038 | Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey |
| Q87716920 | Anaphylactic Shock Caused by a Hidden Allergen in Blood Sausage |
| Q82481274 | Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema |
| Q55056656 | Anaphylactic reaction to probiotics. Cow's milk and hen's egg allergens in probiotic compounds. |
| Q80787337 | Anaphylactic shock caused by tick (Rhipicephalus sanguineous) |
| Q59938196 | Anaphylaxis caused by hemocyanin contained in shrimp cephalothorax |
| Q70916243 | Anaphylaxis to trimethoprim |
| Q58000921 | Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report |
| Q39859568 | Ani s 11-Like Protein Is a Pepsin- and Heat-Resistant Major Allergen of Anisakis spp. and a Valuable Tool for Anisakis Allergy Component-Resolved Diagnosis |
| Q38552342 | Association between pollen hypersensitivity and edible vegetable allergy: a review. |
| Q68204893 | Asthma with sulfite intolerance in children: a blocking study with cyanocobalamin |
| Q85306293 | Bradykinin-mediated hereditary angioedema (non-estrogen-dependent) without C1 inhibitor deficiency |
| Q39098342 | Burden of Illness in Hereditary Angioedema: A Conceptual Model. |
| Q72239807 | Childhood allergic bronchopulmonary aspergillosis |
| Q43296655 | Chronic urticaria caused by folic acid. |
| Q59938185 | Classification of angioedema without wheals |
| Q27009012 | Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group |
| Q40148582 | Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency |
| Q74665066 | Clinical characteristics of patients with mustard hypersensitivity |
| Q33158687 | Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. |
| Q37690007 | Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey. |
| Q48090057 | Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children |
| Q27022061 | Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis |
| Q37945256 | Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. |
| Q71601863 | Cupressaceae pollinosis in the Madrid area |
| Q45893080 | Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. |
| Q35805244 | Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies |
| Q44615977 | Disease expression in women with hereditary angioedema. |
| Q38026489 | Efficacy assessments in randomized controlled studies of acute therapy for hereditary angioedema. |
| Q80805497 | Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series |
| Q37249076 | Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema |
| Q34029593 | Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group |
| Q77807093 | Gastric anisakiasis: an underestimated cause of acute urticaria and angio-oedema? |
| Q73880781 | Gastroallergic anisakiasis: findings in 22 patients |
| Q34067727 | HAE international home therapy consensus document. |
| Q48083763 | Health-related quality of life in Danish patients with hereditary angioedema. |
| Q37065138 | Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. |
| Q50450861 | Hereditary angioedema |
| Q34579883 | Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment |
| Q44901102 | Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease. |
| Q44495008 | Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype |
| Q36555078 | Hereditary angioedema: quality of life in Brazilian patients |
| Q77170208 | Hypersensitivity to piperacillin |
| Q46389923 | Idiopatic angioedema treated with dapsone. |
| Q73909274 | IgE crossreactivity between mugwort pollen (Artemisia vulgaris) and hazelnut (Abellana nux) in sera from patients with sensitivity to both extracts |
| Q77799217 | IgE-mediated anaphylaxis to Thiomucase, a mucopolyssacharidase: allergens and cross-reactivity |
| Q59322750 | Importance of Ara h 6 in peanut allergy diagnosis |
| Q59938207 | Long-term prophylaxis with C1-inhibitor concentrate in patients with hereditary angioedema |
| Q33698175 | Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice |
| Q38871882 | Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency. |
| Q34181274 | Management of hereditary angioedema in pregnant women: a review. |
| Q46084303 | Microarrayed Jug r 1 shows the best diagnostic performance in walnut allergy. |
| Q39290675 | Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting |
| Q86090780 | Nonhistaminergic idiopathic angioedema: clinical response to icatibant |
| Q45984666 | Occupational asthma caused by artificial cyanoacrylate fingernails. |
| Q50506590 | Occupational asthma due to western red cedar in a guitar maker. |
| Q39213357 | Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. |
| Q59938218 | Peanut seed storage proteins are responsible for clinical reactivity in Spanish peanut-allergic children |
| Q40170078 | Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients |
| Q64049020 | Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema |
| Q39927203 | Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL. |
| Q38198050 | Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable? |
| Q72640645 | Relationship between pollinosis and fruit or vegetable sensitization |
| Q36646147 | Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain. |
| Q33929615 | Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. |
| Q85278887 | Specific immunoglobulin E to Echinococcus granulosus in children allergic to cow's milk proteins |
| Q36967735 | The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks |
| Q39309234 | The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. |
| Q112241369 | The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update |
| Q77331477 | Tomato allergy in children and young adults: cross-reactivity with latex and potato |
| Q38375740 | Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema |
| Q40796414 | Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals |
| Q46323930 | Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. |
| Q72707314 | Urticaria induced by caffeine |
| Q59938235 | Usefulness of abdominal ultrasonography in the follow-up of patients with hereditary C1-inhibitor deficiency |
| Q78197084 | Usefulness of early serial measurement of specific and total immunoglobulin E in the diagnosis of gastro-allergic anisakiasis |
| Q95541426 | Usefulness of oral food challenge and a visual analog scale in the etiologic diagnosis of eosinophilic esophagitis |
| Q52822104 | Utility of specific IgE to Ara h 6 in peanut allergy diagnosis. |